Autori: Antonaci L

Filtra

Data

Early neurological signs in infants identified through neonatal screening for SMA: do they predict outcome?

Communicative development inventory in type 1 and presymptomatic infants with spinal muscular atrophy: a cohort study

Profile of cognitive abilities in spinal muscular atrophy type II and III: what is the role of motor impairment?

Early treatment of type II SMA slows rate of progression of scoliosis

Caregivers’ Expectations on Possible Functional Changes following Disease-Modifying Treatment in Type II and III Spinal Muscular Atrophy: A Comparative Study

Long term follow-up of scoliosis progression in type II SMA patients

Nusinersen efficacy data for 24-month in type 2 and 3 spinal muscular atrophy

Revised upper limb module in type II and III spinal muscular atrophy: 24-month changes

Motor function in type 2 and 3 SMA patients treated with Nusinersen: a critical review and meta-analysis

Different trajectories in upper limb and gross motor function in spinal muscular atrophy

Torna in alto